BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,972,000 | -84.1% | 20,400 | -87.0% | 0.01% | -81.8% |
| Q1 2022 | $18,659,000 | -32.2% | 157,363 | -21.2% | 0.06% | -6.8% |
| Q4 2021 | $27,533,000 | +19.4% | 199,793 | +20.3% | 0.06% | +13.5% |
| Q3 2021 | $23,062,000 | +418.0% | 166,022 | +262.0% | 0.05% | +420.0% |
| Q2 2021 | $4,452,000 | -52.3% | 45,857 | -66.4% | 0.01% | -58.3% |
| Q1 2021 | $9,337,000 | -44.4% | 136,605 | -30.3% | 0.02% | -50.0% |
| Q4 2020 | $16,788,000 | -6.4% | 195,875 | -29.0% | 0.05% | -25.0% |
| Q3 2020 | $17,934,000 | +182.8% | 275,865 | +218.0% | 0.06% | +106.5% |
| Q2 2020 | $6,342,000 | +119.4% | 86,744 | +2.1% | 0.03% | +29.2% |
| Q1 2020 | $2,891,000 | -78.7% | 84,963 | -65.9% | 0.02% | -41.5% |
| Q4 2019 | $13,582,000 | +442.0% | 249,479 | +315.4% | 0.04% | +412.5% |
| Q3 2019 | $2,506,000 | +264.2% | 60,060 | +282.5% | 0.01% | +300.0% |
| Q2 2019 | $688,000 | -94.1% | 15,700 | -93.1% | 0.00% | -94.7% |
| Q1 2019 | $11,718,000 | +3346.5% | 227,666 | +1571.8% | 0.04% | +3700.0% |
| Q2 2017 | $340,000 | – | 13,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |